URGN insider buying and SEC filings, explained
UroGen Pharma Ltd. · CIK 1668243
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.2M
Planned sales (10b5-1)
$1.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 8, 2026 | Sale | Mark Schoenberg (Chief Medical Officer) sold 871 shares at $42.92 ($37K). Holdings down 1% to 59,882 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 9, 2026 |
| Sep 8, 2026 | Sale | Jason Drew Smith (General Counsel) sold 1,519 shares at $42.54 ($65K). Holdings down 3% to 53,141 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 9, 2026 |
| Aug 20, 2026 | Sale | Mark Schoenberg (Chief Medical Officer) sold 60,677 shares at about $47.05 ($2.9M). Holdings down 51% to 59,086 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 24, 2026 |
| Jul 9, 2026 | Planned (10b5-1) | Mark Schoenberg (Chief Medical Officer) sold 10,000 shares at about $40.00 ($400K), marked as a 10b5-1 plan trade. Holdings down 8% to 119,763 shares. | SEC filing Filed Jul 10, 2026 |
| Jun 22, 2026 | Planned (10b5-1) | Mark Schoenberg (Chief Medical Officer) sold 10,000 shares at about $35.01 ($350K), marked as a 10b5-1 plan trade. Holdings down 7% to 129,763 shares. | SEC filing Filed Jun 24, 2026 |
| May 8, 2026 | Planned (10b5-1) | Mark Schoenberg (Chief Medical Officer) sold 10,000 shares at about $30.00 ($300K), marked as a 10b5-1 plan trade. Holdings down 7% to 134,985 shares. | SEC filing Filed May 11, 2026 |
| Feb 3, 2026 | Sale | Jason Drew Smith (General Counsel) sold 7,479 shares at $19.69 ($147K). Holdings down 12% to 55,588 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 11, 2026 |
| Feb 3, 2026 | Sale | Mark Schoenberg (Chief Medical Officer) sold 7,373 shares at $19.69 ($145K). Holdings down 5% to 144,985 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 4, 2026 |
| Nov 19, 2025 | Planned (10b5-1) | Mark Schoenberg (Chief Medical Officer) sold 10,000 shares at about $25.00 ($250K), marked as a 10b5-1 plan trade. Holdings down 7% to 139,025 shares. | SEC filing Filed Nov 20, 2025 |
24 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow URGN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.